Breaking: @lyphedispensary has launched the V range to UK patients.
Find out more about what that means for patients and the sector below 👇
https://t.co/5et9UqIkWT
Breaking: @lyphedispensary has launched the V range to UK patients.
Find out more about what that means for patients and the sector below 👇
https://t.co/5et9UqIkWT
Nice milestone for the new business - our first commercial filming job for the @UKCanCouncil at @Fieldfisher Law Firm.
Cracking event - speakers were spot on and enjoyed recording tons of vox pops with Holly.
Kamala Harris has taken a bold step, endorsing full cannabis legalisation.
She emphasised the need to stop criminalising cannabis use, particularly for marginalised communities disproportionately affected by drug laws.
Read more:
https://t.co/Ld5RBM1RkI
5/ The study calls for education, reform, and better access to NHS prescriptions to reduce inequality.
Full article and breakdown here:
https://t.co/QvKFokDzQ7
🧵1/ Cannabis has been legal for medical use in the UK since 2018, but patients still face stigma. A new study explores how prohibitionist attitudes persist. 👇
https://t.co/QvKFokDzQ7
8/ The rise in ketamine use demands action, not panic. Let’s ensure young people are empowered with the knowledge and support they need to make safer decisions. #DrugEducation#HarmReduction#Ketamine
https://t.co/raZz09Iu5u
🧵 Is Ketamine Use Among Young People in the UK a Growing Crisis?
1/ Recent data shows an increase in ketamine use among young people, but is it a crisis or a moderate rise? Let's dive into the stats and health impacts of this dissociative drug.
https://t.co/raZz09Iu5u
7/ Schools, universities, and harm reduction services must offer up-to-date, evidence-based education on ketamine’s risks, focusing on safer use and treatment options. Prevention starts with awareness! 🧠
🔄 Industry Impact: These updates bring CBPMs in line with other unlicensed medicines. While improving quality, they may cause short-term disruptions for businesses and patients alike. #CannabisIndustry
(6/6)
Read here: https://t.co/FttRq2zSLx
🚫 Communication Restrictions: Companies are prohibited from directly communicating with patients about products. Instead, all communication must go through clinicians or pharmacists. #PatientSafety
(5/6)